MD-PhD Human Genetics student, Mark Sorin has received the FRQS' Jacques-Genest Rising Star Award for his contributions towards paper published in Nature titled 'Single-cell spatial landscapes of the lung tumour immune microenvironment'. Read more.

Published on: 6 Feb 2024

The following announcement is being sent on behalf of Dr. Vicky Tagalakis, Physician-in-Chief:


Dear Colleagues,


We are delighted to announce the appointment of Dr. William Foulkes as the Chief of the Division of Medical Genetics in the Jewish General Hospital Department of Medicine, effective January 1, 2024.


Dr. Foulkes is a three-time graduate of the University of London, holding a BSc in Anatomy, a Bachelor of Medicine and Bachelor of Surgery, and a PhD in Molecular Genetics.


Published on: 7 Dec 2023

Established in 1993, McGill University’s world-renowned Department of Human Genetics is celebrating its 30th anniversary. Join us for a walk down memory lane with past and present Chairs David Rosenblatt, Eric Shoubridge and William Foulkes.

Published on: 3 Nov 2023

Though we all share common ancestors ranging from a few generations to hundreds of thousands of years, genealogies that relate all of us are often forgotten over time. A new McGill University-led study is now providing insight into the complex relationship between human migration and genetic variation, using a unique genealogical dataset of over five million records spanning 400 years to unravel the genetic structure of French Canadian populations.

Classified as: French Canadians, genetics, genealogical records, relatedness, genealogies, human migration
Published on: 25 May 2023

First study of humans with a rare immunodeficiency reveals how the immune system protects the body against pathogens known to cause serious diseases, such as tuberculosis and COVID-19. The research involving McGill University, paves the way for new therapies to treat autoimmune diseases, chronic inflammatory diseases, and new approaches to vaccine development.

Classified as: immune system, covid-19, Immunodeficiency, tuberculosis, autoimmune diseases, chronic inflammatory disease, vaccine development
Published on: 8 May 2023

A receptor for the dopamine neurotransmitter promotes growth and spread of pancreatic cancer -- and schizophrenia drugs, which block the function of this receptor, slowed tumor growth and metastatic spread in mice, according to researchers at McGill University and the German Cancer Research Center.

Classified as: schizophrenia, Cancer, Genome Québec, Riazalhosseini, pancreas, pancreatic
Published on: 7 Sep 2016
Back to top